Medicine
MiloPhene 50 mg tablet
MiloPhene 50 mg tablet is a prescription medicine containing Clomiphene for oral use, marketed by Burel Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store tablets at controlled room temperature 15° to 30°C (59° to 86°F)…
Key facts
- Active ingredient (INN)
- Clomiphene
- Brand
- MiloPhene
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 10 tablets
- Marketing authorisation holder
- Burel Pharmaceuticals
- Manufacturer
- Burel Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store tablets at controlled room temperature 15° to 30°C (59° to 86°F). Protect from heat, light, and excessive humidity, and store in closed containers.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03GB02 Clomiphene
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 August 2025
- Identifiers
- RxCUI 1093060, 2723329DailyMed set ID b56131e5-efc7-43af-ac13-4a2ae918df4eNDC 35573-470Application ANDA072196
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 35573-470-30 | Burel Pharmaceuticals | 15 August 2025 |
| 10 tablet in 1 bottle | 35573-470-75 | Burel Pharmaceuticals | 1 December 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 1 February 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clomiphene 50 mg tablet.
Clinical summary
Clomiphene is an estrogen agonist/antagonist indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. It is available as tablets for oral use. MedsAcross supplies Clomiphene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClomipheneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clomiphene Citrate prescribing information (Accord Healthcare) · U.S. National Library of Medicine, DailyMed
Need MiloPhene 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.